Stylus Medicine
2 employees
Biotech
Series A · $85.0M
Open positions (1)
Company details
Team Size2
IndustryBiotech
Funding
Total raised
$85.0M
Last stage
Series A
Investors
Chugai Venture Fund
Total raised
$85.0M
Last stage
Series A
Investors
Patrick Hsu
Scientific founder of Stylus Medicine. Co-founder of the Arc Institute and Assistant Professor of Bioengineering at UC Berkeley. His research on large serine recombinases underlies Stylus's gene insertion platform.
LinkedInEmile Nuwaysir
Serial biotech entrepreneur with 25+ years in cell and gene therapy. Previously CEO of BlueRock Therapeutics (Bayer) and Ensoma. Leads Stylus Medicine as Chairman and CEO.
Jason Fontenot
Chief Scientific Officer of Stylus Medicine, part of the founding leadership team alongside CEO Emile Nuwaysir.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.